Head-to-head · Cost-Efficiency Index
VitaStir vs Wisp
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
VitaStir
Cost-first shoppers who want michigan residents who want in-person clinic visits alongside an at-home GLP-1 option.
Visit VitaStirWisp
Cost-first shoppers who want branded injectables plus a sublingual semaglutide alternative.
Visit WispThe verdict
VitaStir and Wisp tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers. For most shoppers we'd start with VitaStir (ranked #201, a hair above #202) — Cost-first shoppers who want michigan residents who want in-person clinic visits alongside an at-home GLP-1 option. But Wisp is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs VitaStir.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | VitaStir | Wisp |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $125/mo (compounded) | $225/mo (compounded oral) |
| Tirzepatide / mo | $145/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,500 | $2,700 |
| Tirzepatide / yr (modeled) | $1,740 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #201 | #202 |
VitaStir
63/100Where the value is
- Real physical clinic locations with in-person options, not purely virtual
- Displays a LegitScript approved badge and states PCAB pharmacy licensing
- Low headline sale prices on both semaglutide and tirzepatide homekits
The tradeoffs
- Physical footprint is Michigan-only -- not a true nationwide option despite an online-order path
- Large 'reduced from' discounts (64-79% off) with no expiration date look like a permanent pricing anchor, not a real promo
Wisp
63/100Where the value is
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
The tradeoffs
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.